Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)
Clinical trial NCT04120883 · TERMINATED
Trial details
- NCT number
- NCT04120883
- Sponsor
- University of Michigan
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2024-08-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.